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Vesicle aggregationLipid peroxidation plays a central role in the pathogenesis ofmanydiseases like atherosclerosis andmultiple scle-
rosis. We have analyzed the interaction of sphingosine with peroxidized bilayers in model membranes. Cu2+
induced peroxidation was checked following UV absorbance at 245 nm, and also using the novel Avanti
snoopers®. Mass spectrometry conﬁrms the oxidation of phospholipid unsaturated chains. Our results show
that sphingosine causes aggregation of Cu2+-peroxidized vesicles. We observed that aggregation is facilitated
by the presence of negatively-charged phospholipids in the membrane, and inhibited by anti-oxidants
e.g. BHT. Interestingly, long-chain alkylamines (C18, C16) but not their short-chain analogues (C10, C6, C1)
can substitute sphingosine as promoters of vesicle aggregation. Furthermore, sphinganine but not sphingosine-
1-phosphate can mimic this effect. Formation of imines in the membrane upon peroxidation was detected by
1H-NMR and it appeared to be necessary for the aggregation effect. 31P-NMR spectroscopy reveals that sphingosine
facilitates formation of non-lamellar phase in parallel with vesicle aggregation. The data might suggest a role for
sphingosine in the pathogenesis of atherosclerosis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Peroxidation of membrane lipids consecutive to oxidative stress in
cells has been shown to affect the bilayer biophysical properties, facili-
tating phospholipid ﬂip-ﬂop or promoting phase separation among
other effects [1–5]. Oxidized phospholipids are known to acquire new
biological activities not present in their unoxidized precursors, which
may modify patho/physiological processes such as multiple sclerosis
and atherosclerotic lesions [6,7]. Atherosclerosis is the most common
cause for cardiovascular disease and is characterized by inﬂammation,
cell death,ﬁbrosis, and lipid andmacrophage accumulation, cholesterol,
glycerophospholipids and sphingolipids being commonly found in the
lesions [8,9].
Although the overall effect of sphingolipids in the atherosclerotic
process is not clear, it is well established that e.g. inhibition of3-phosphocholine); 1H-NMR,
ity lipoprotein); Liss Rho PE,
ine); PAPC, (1-palmitoyl-2-
atidic acid); PC, (phosphatidyl
sphatidyl inositol); 31P-NMR,
hingomyelin); Top Fluor Cer1P,
sity lipoprotein)sphingolipid synthesis can reduce circulating VLDL in hamsters and
decrease plasma triglycerides that represent a risk factor for cardiovas-
cular disease [10]. Furthermore, sphingosine-1-phosphate increases
continuously with atherosclerotic damage and correlates inversely
with HDL levels [11,12]. Less attention has been paid to molecules
such as sphingosine and sphinganine whose concentrations in serum
and plasma are relatively low, probably because they are being converted
to sphingosine-1-phosphate and sphinganine-1-phosphate by blood cells
[13]. However it has been reported that oxidized LDL increases the
activities of both acidic and alkaline ceramidases in smooth muscle cells
and elevate cellular sphingosine as well as S1P [14]. Moreover sphingo-
sine is known to inﬂuence membrane biophysical properties, increasing
the permeability of model and cell membranes [15] and modifying the
thermotropic behaviour of lipids among other effects [1,15–19].
Since it is clear that both lipid peroxidation [20] and sphingolipids
with membrane-perturbing effects are present in atherosclerotic
lesions, it is intriguing whether this pathological process will also be
mediated via changes in membrane properties besides thewidely stud-
ied protein signaling pathways. The purpose of this studywas to analyze
the possible differences in the interaction of sphingosine with non-
oxidized and peroxidized bilayers using model membrane systems,
which may help us to understand issues that are more difﬁcult to
study in vivo. Vesicles composed of different lipid mixtures have been
tested, but most assays have been performed with SM:PE:Ch (2:1:1,
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with that mixture. Our results indicate that sphingosine induces the
aggregation of peroxidized lipid vesicles and that this effectmay beme-
diated by the formation of imines or Schiff bases detected by 1H-NMR,
as well as by the ability of sphingosine to facilitate the formation of
non-lamellar phases in peroxidized bilayers. Since the aggregation of
oxidized vesicles can be considered as a model for oxidized lipoprotein
aggregation in atherosclerotic lesions [21,22], the ﬁnding that sphingo-
sine induces vesicle aggregation may point to this lipid as a novel
component in the pathogenesis of atherosclerosis.
2. Materials and methods
2.1. Materials
Sphingosine, sphingomyelin, egg PA, liver PI, egg PC, PAPC, DMPC,
TopFluor Cer1P, LissRho PE, E06 Mouse Monoclonal Antibody (IgM)
(330001) and cholesterol were from Avanti Polar Lipids, Inc. (Alabaster,
AL, USA). Egg PE (22% C16:0, 37.4% C18:0, 29.4% C18:1, 11.2% C18:2)
was purchased from Lipid Products (South Nutﬁed, UK). Stearylamine,
hexadecylamine, dodecylamine, hexylamine, methylamine and 3,5-di-
tert-4-butylhydroxytoluene (BHT) (47168) were from Sigma (Madrid,
Spain). Copper dichloride dihydrate (CuCl2 × 2H2O) (102733) was
from Merck (Darmstadt, Germany).
2.2. Methods
2.2.1. Vesicle preparation
LUV of diameters 100–150 nm were prepared by the extrusion
method [23] using Nuclepore ﬁlters of 0.1 μm pore diameter, at a tem-
perature above the transition temperature of the mixtures (40 °C), in
10mMHEPES, 150mMNaCl, pH 7.4. For multilamellar (MLV) liposome
preparation the lipidswere dissolved in chloroform:methanol (2:1) and
mixed in the required proportions, and the solvent was evaporated to
dryness under a stream of nitrogen. Traces of solvent were removed
by leaving the samples under high vacuum for at least 2 h. The samples
were hydrated in 10 mM HEPES, 150 mM NaCl, pH 7.4 helping disper-
sion by stirring with a glass rod. The ﬁnal phospholipid concentration
of both LUV and MLV was measured as lipid phosphorous [24].
2.2.2. Lipid peroxidation assay
LUV of appropriate composition, usually SM:PE:Ch (2:1:1, mol
ratio), with or without either 5% PA or 5% PI, were incubated at 37 °C
after addition of CuCl2 (10 μM) at time zero. Copper-induced oxidation
was checked at 245 nm every hour according to Schnitzer et al. [25],
1 mg/mL lipid as a liposome preparation being added to 3 mL absolute
ethanol [26]. Measurements were carried out in a Uvikon 922 spectro-
photometer (Kontron instruments, Groß-Zimmern, Germany), using
quartz cuvettes with absolute ethanol in the reference cell.
2.2.3. Snooper testing for the detection of lipid peroxidation
Avanti snoopers® consist of a solid support on which lipids can be
spotted. In our case snoopers were prepared according to the layout in
Fig. 3 and containing 0.64 nmol, 1.28 nmol, or 1.92 nmol LUV composed
of SM:PE:Ch (2:1:1, mol ratio) + 5% PA. Snooper strips were blocked
with 3% BSA (fatty acid free) in TBS (0.8% NaCl, 20 mM Tris–HCl
pH 7.4). The blocked membranes were then probed with E06
(200 ng/mL) in TBS containing 1% BSA for 1 h at room temperature.
After washing the membranes 3 times with TBS the bound antibody
was detected with goat anti-mouse IgM conjugated to HRP (Southern
Biotech, Birmingham, AL, USA) at a 1:10,000 dilution in TBS containing
1% BSA for 1 h at room temperature. After washing, bound HRP was vi-
sualized on an X-ray ﬁlm with an enhanced chemiluminescence
substrate (Pierce Biotechnology, Rockford, IL, USA). Additional lipid
snoopers were also stained with molybdenum blue, which forms a
complex with phosphorous and can be used to verify the presence ofphosphorous containing lipids. Fluorescent reference lipids were used
to enable the user to identify the orientation of the strip. As a positive
control, Avanti Lipid Snoopers® containing 1.28 nmol of PAPC were
prepared and allowed to air oxidize for 72 h, and probed with E06 in
order to conﬁrm the ﬁdelity of the antibody.
2.2.4. Vesicle aggregation
Liposome aggregation was induced by addition of sphingosine or
other alkylamines to peroxidized vesicles. At preﬁxed time intervals
after Cu2+ addition aliquots were removed from the vesicle suspension
undergoing peroxidation. Aggregation was assayed as an increase in
turbidity (absorbance at 400 nm) measured in a Uvikon 922 (Kontron
instruments, Groß-Zimmern, Germany) spectrophotometer.
2.2.5. Stopped-ﬂow kinetics
The rates of aggregation kinetics at increasing sphingosine concen-
trations were determined using a stopped-ﬂow spectrophotometer
SFM-3 (BioLogic, France). 0.6 mM peroxidized LUV composed of SM:
PE:Ch (2:1:1) + 5% PA were mixed each time with sphingosine
solutions of different concentrations in 1:1 volume proportions to a
0.3 mM ﬁnal LUV concentration.
2.2.6. Nuclear magnetic resonance
60 mM lipid in the form of MLV was incubated with 10 μM CuCl2 at
37 °C for 1 24 h in order to undergo peroxidation and transferred to
5 mm NMR tubes. Data acquisition was performed in a Bruker AV500
spectrometer (Rheinstetten, Germany) operating at 202.45 MHz for
31P, and 500 MHz for protons, with a 5 mm BBI probe with gradients
in the Z-axis, at increasing temperatures in the case of 31P. The data
were recorded and processed with the software TOPSPIN 1.3 (Bruker,
Austria).
2.2.7. Mass spectrometry
Samples were lyophilized then reconstituted with 500 μL 65:35:8
chloroform:methanol:water using a 1 mL Hamilton syringe. This
approximately 5 mM solution was slightly cloudy. Four drops of
methanol + 1 mM ammonium acetate were added and the sample
solutions were then clear. The samples were then diluted 1:5 with
methanol + 1 mM ammonium acetate such that the concentration
was approximately 1 mM. “Without column” scans were performed
by ﬂow infusion via an autosampler using an Agilent 1100 Series HPLC
and an ABSciex 4000 QTrap mass spectrometer. Injection volume =
5 μL. “With column” scans were performed using a Waters Acquity
UPLC and an ABSciex QTrap 5500. Injection volume= 1 μL. The column
was an Agilent XDB-C8 1.8 μm 4.6 × 50 mm (S.N. = USHAN01858).
Themobile phaseswereA= 70:30methanol:water+5mMammonium
acetate and B = methanol + 5 mM ammonium acetate. Flow rate =
1.0 mL/min.
3. Results
3.1. Sphingosine-induced vesicle aggregation during copper-induced
peroxidation
Peroxidation of LUV consisting of SM:PE:Ch (2:1:1, mol ratio) + 5%
PA or PI was followed as UV absorbance at 245 nm and at pre-ﬁxed
times aliquots of the sample were taken for the aggregation measure-
ments. Peroxidation increased at a fast rate for 2–3 h, and then it went
on more slowly for a long time (Fig. 1 A). The presence of negatively-
charged lipids did not modify markedly the rate or extent of peroxida-
tion. The peroxidation process was paralleled by vesicle aggregation in
the presence of sphingosine. Aggregation was in this case facilitated
by the presence of negatively charged phospholipids in the membrane
(Fig. 1 B). This is probably due to electrostatic forces that facilitate the
interaction between sphingosine and negatively charged bilayers.
Other compositions were tried including vesicles composed of PC, PC:
Fig. 1. Copper-induced vesicle peroxidation and sphingosine-induced vesicle aggregation.
LUVs composed of SM:PE:Ch (2:1:1 mol ratio) ± 5 mol.% PA or PI. (A) Copper-induced
peroxidation. 1 mg/mL of lipid was dissolved in absolute ethanol for the measurements
of OD 245 nm. (B) Sphingosine-induced vesicle aggregation after 3 h of copper-induced
oxidation. 0.3 mM of LUV was prepared and 20% sphingosine was added. Control experi-
ments with EDTA (chelating agent) (200 μM) and BHT (antioxidant) (50 μM) are also
shown in both cases.
Fig. 2. Time course of sphingosine-induced aggregation. LUVswere composed of SM:PE:Ch (2:1
vesicle aggregation. (B) Turbidity measurements of sphingosine-induced vesicle aggregation. D
kinetics, induced by different sphingosine concentrations. Values were ﬁtted to a linear polyno
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oxidationwas detected following the addition of CuCl2 and sphingosine
or long chain amines (see below) were able to induce vesicle aggrega-
tion, although to a lesser extent than with the SM:PE:Ch mixture (data
not shown). Pure egg PC bilayers were particularly resistant to aggrega-
tion. Moreover the fact that vesicle aggregation can be inhibited by the
antioxidant BHT conﬁrms that this effect is a direct consequence of
membrane peroxidation (Fig. 1).
To study in further detail this aggregation process the time course of
aggregation of LUV composed of SM:PE:Ch (2:1:1, mol ratio) + 5% PA
was recorded at increasing sphingosine concentrations. A stopped-
ﬂow spectrophotometer was used to study aggregation from its
initial steps. As seen in Fig. 2 A, no aggregation was detected in the
non-oxidized bilayer. However, when the membrane was peroxidized,
sphingosine induced an increase in turbidity (A400) in a dose-
dependent manner (Fig. 2 B). As shown in Fig. 2 C, aggregation rates
were higher as sphingosine concentration was increased, showing
that the process was also dose-dependent for sphingosine.3.2. Validation of the capacity of E06 antibody to recognize peroxidized
liposomes: a novel method to test lipid peroxidation in membranes
Avanti E06 antibody recognizes the phosphocholine group of oxi-
dized but not of non-oxidized phospholipids [27]. As seen in Fig. 3 A, a
signal was obtained speciﬁcally for the oxidized sample, suggesting
that it is possible to probe peroxidation in our lipid system using the
Avanti snoopers. Different snoopers were stained with molybdenum
blue, which forms a complex with phosphorous and can be used to de-
tect the presence of phosphorous-containing lipids. Fig. 3 B shows the
presence of lipids in all the samples, therefore the fact that a chemilumi-
nescent signal was not detected for the non-oxidized samples probed
with E06 is not the result of a differential afﬁnity of these samples for
the membrane, but rather of the speciﬁcity of the antibody to its
substrate. Finally, snoopers containing oxidized PAPC were probed:1, mol ratio)+ 5%PA. (A) Time-course of turbiditymeasurements of sphingosine-induced
ifferent mol.% sphingosine were added at time 0. (C) Rate constants of vesicle aggregation
mial equation (r2 = 0.986).
Fig. 3. Snooper testing of lipid peroxidation. (A) Chemiluminescent detection of lipid peroxidation. Avanti® snoopers were prepared according to the layout in the ﬁgure containing
(1) 0.64, (2) 1.28, or (3) 1.92 nmol of LUV composed of SM:PE:Ch (2:1:1, mol ratio) + 5% PA. (B)Molybdenum staining to prove phospholipid presence. Molybdenum blue forms a com-
plex with phosphorous containing lipids. (5) 0.64, (6) 1.28, or (7) 1.92 nmol of LUV composed of SM:PE:Ch (2:1:1, mol ratio) + 5 mol.% PA. (C) Positive control. Avanti® snoopers were
prepared according to the layout in the ﬁgure containing 1.28 nmol of PAPC, which was allowed to air-oxidize for 72 h. (9) Chemiluminescent detection, (10) molybdenum staining.
Fig. 4. Other alkylamines as promoters of vesicle aggregation. Sphingosine and other
alkylamine-induced aggregation of vesicles composed of SM:PE:Ch (2:1:1) + 5 mol.%
PA during their oxidation. At time zero CuCl2 (10 μM) was added.
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(Fig. 3 C) in order to conﬁrm the speciﬁcity of the antibody and to
serve as a positive control.
3.3. Other alkylamines as promoters of vesicle aggregation
In order to ﬁnd out which was the sphingosine functional group re-
sponsible for the promotion of vesicle aggregation, chain-length depen-
dent aggregation studies were carried out. For this purpose, different
chain length amines were used and compared with the effect of the
sphingosine. Vesicles were incubated in the presence of 10 μM CuCl2
at 37 °C and aliquots were taken at pre-established time points for tur-
bidity assays. The results are shown in Fig. 4. Long chain alkylamines
(C18, C16) can substitute sphingosine as promoters of vesicle aggrega-
tion. The effect of stearylamine (C18) was actually more pronounced
than that of sphingosine (Fig. 4). However, the chain length of short
alkylamines (C10, C6, C1) appears to be insufﬁcient to promote vesicle
aggregation, probably because it is not enough to facilitate a proper
insertion of the molecule in the bilayer. Thus besides the amino group,
a long alkyl chain appears to be required for sphingosine to exert its
vesicle aggregation effect.
Furthermore the head group of sphingosine appears to be necessary
for this aggregation to occur since its saturated analogue sphinganineinduces aggregation while sphingosine-1-phosphate does not (data
not shown). Perhaps the net positive charge of sphingosine is important
in this respect.
Fig. 6. 1H-RMN of vesicles composed of SM:PE:Ch (2:1:1, mol ratio) + 5 mol.% PA after
copper-induced peroxidation showing the detection of imines in the sample.
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It had been shown earlier that peroxidation of membrane lipids
modiﬁed their structures, which in turn might affect membrane bio-
physical properties, including the formation of non-lamellar struc-
tures [28]. 31P-NMR is a useful tool in the detection of non-lamellar
phases. Experiments were performed using multilamellar vesicles and
increasing temperatures, in order to facilitate the transition from lamel-
lar to non-lamellar structures. As seen in Fig. 5, an isotropic signal starts
to appear above 65 °C in both cases, vesicles with and without sphingo-
sine. However in the peroxidized vesicles composed of SM:PE:Ch (2:1:1,
mol ratio) + 5% PA only a weak signal can be detected (Fig. 5 A), while
in the vesicles containing sphingosine the signal is larger, becomingpre-
dominant at 85 °C. The isotropic signal could indicate the presence of a
non-lamellar phase. (Note that the relatively poor signal-to-noise ratio
of the spectra containing sphingosine is due to sample inhomogeneities
due to the tendency of these vesicles to aggregate and precipitate). The
isotropic signal observed in the presence of sphingosine is not due to
the presence of micelles or small vesicles, because no signiﬁcant phos-
pholipid solubilization could be observed under our conditions.
3.5. Detection of imines upon copper-induced peroxidation
1H-NMR has been used to detect the presence of imines in
peroxidized vesicles composed of SM:PE:Ch (2:1:1, mol ratio) + 5%
PA based on previous published data [29]. A signal assigned to imine
protons was detected in these vesicles before and after the addition of
20 mol.% of sphingosine (Fig. 6), while no imine formation was found
in MLV with compositions (e.g. pure egg PC) in which sphingosine did
not induce vesicle aggregation (data not shown), showing a clear rela-
tionship between lipid peroxidation, imine formation in the membrane
and sphingosine-induced aggregation.
3.6. Mass spectrometry analysis
The PE component of our vesicles is the likely candidate to undergo
formation of a Schiff base. In order to monitor formation of a simple
Schiff base, we began by looking for a shift of +13 amu. We attempted
this by scanning each of the samples (non-oxidized, oxidized, and oxi-
dized + 20% sphingosine) in positive (+Q1) ion mode. This small
shift is extremely difﬁcult to monitor and more difﬁcult to interpret in
the mass spectra of a natural lipid or a mixture of natural lipids. This
idea was reﬂected in the collected spectra, as we were unable to visual-
ize any distinct differences in these initial scans. In further attempting to
identify differences within the samples, a column was used to separate
the lipid classes prior to looking for a neutral loss of 141 (+NL141),
which is characteristic of PE species. As shown in pages 19–21 of the
Supplementary Material 1, notable differences in chromatography of
the +NL141 scans were seen between the three samples reﬂecting al-
terations of the PE species. Next, a precursor scan of 184 (+Prec 184)Fig. 5. 31P-NMR experiments of the mixture SM:PE:Ch (2:1:1, mol ratio) + 5 mol.% PA oxidi
sphingosine.was performed on the samples in order to look for changes in the
sphingomyelin species, although it is unlikely that the tertiary amine
would undergo a Schiff base formation. As shown on pages 16–18 of
the attached pdf, the differences in chromatography of the +Prec 184
scans, reﬂecting changes in sphingomyelin species, were not very pro-
nounced between the three samples, suggesting that it is the PE species
which is most affected by the copper chloride oxidation. In an attempt
to identify aldehyde-modiﬁed PE species formed as a result of oxidation,
neutral loss scans of 168 (PE+ 28) and 182 (PE+ 42) were performed.
These were chosen because they were the most abundant aldehyde
modiﬁcations resulting from copper oxidation in the study by Guo
et al. [30]. Unfortunately, we were unable to see any peaks above
noise in these samples. However, in more closely examining
the +NL141 scans (pages 19–21 of the Supplementary Material 1),
the most pronounced differences occurred in the m/z range of 450–
700 reﬂecting the possibility of speciﬁc oxidized acyl chains. In order
to identify speciﬁc acyl chains undergoing oxidative changes, precursor
scans of 283, 281, 279, 255, and 303, which correspond to C18:0, C18:1,
C18:2, C16:0, and C20:4 respectively, were performed. These scans
comprise pages 1–15 of the Supplementary Material 1. From these
scans, the “List of Peaks” table in the SupplementaryMaterial 2 was cre-
ated. Thisﬁle lists each peak seen for each scan, and it identiﬁeswhether
it was present in the non-oxidized, oxidized, or oxidized + 20% sphin-
gosine sample. Taking this data one step further, multiple reactionmon-
itoring (MRM) transitions were then set up for the peaks present in the
oxidized samples but not present in the non-oxidized samples. From
these scans, peak intensity was then recorded, “Ox Differing Peaks” in
Supplementary Material 2, and can be used to monitor the abundance
of putative species. For some of the species, potential structures can be
proposed (Supplementary Material 3). Please note that these are sug-
gested structures only, as we have no conﬁrmatory data to back upzed after the addition of CuCl2 (10 μM) (A) without sphingosine and (B) with 20 mol. %
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speciﬁc aldehyde-modiﬁcations of the PE species, we did ﬁnd multiple
acyl chain differences between the samples. Observation of the actual
imine or aldehyde-modiﬁed PE species by mass spectroscopy was
perhaps made more difﬁcult considering that such species might be
forming a complex with the copper used as an inductor of oxidation.4. Discussion
Lipid peroxidation is a biologically relevant event that takes place
in cells under certain conditions such as oxidative stress. The study of
this complex process with model membranes is a simpliﬁed method
to understand the molecular mechanisms involved. In this paper we
show that lipid peroxidation can be linked to vesicle, and perhaps lipo-
protein, aggregation through sphingosine, the basic building block of
sphingolipids. In our study, Cu2+-induced peroxidation of lipid bilayers
took place following standard procedures [25,31,32]. From themethod-
ological point of view it is worthmentioning that a simple strip assay for
lipid peroxidation has been validated (Fig. 3). Moreover the phenome-
non of sphingosine-dependent vesicle aggregation deserves some
comment.
Sphingosine induces extensive aggregation of peroxidized vesicles
composed of SM:PE:Ch (2:1:1, mol ratio) with or without 5 mol.% of a
negatively-charged lipid (PA, PI) (Fig. 1). However aggregation of
negatively charged vesicles starts at earlier stages of the peroxidation
process. It is likely that aggregation is facilitated by electrostatic interac-
tion between the positively charged sphingosine and the bilayer. This
aggregation is peroxidation-dependent since the addition of an antiox-
idant abolishes sphingosine-induced aggregation. Both the increase in
absorbance (extent of aggregation) and the rate of the aggregation reac-
tion are dose-dependent for sphingosine under our conditions (Fig. 2).
Note that the negative charge in the bilayer enhances peroxidation by
increasing the binding of copper to the interface [22] so that the effect
of negatively-charged lipids on the aggregation of peroxidized lipo-
somes is likely to be a complex function of the experimental conditions,
including reagent concentration and time of addition. The involvement
of sphingosine in peroxidation-dependent aggregation underlines the
importance of the control of sphingosine levels in cells, which are usual-
ly very low, although under certain circumstances they can be increased
[33–35] and its effects are ampliﬁed [36,37]. The presence of small
amounts of this molecule is known to have a clear impact on the
membrane structure [15]. Our 31P-NMR data (Fig. 5) agree with this
latter observation since sphingosine is clearly facilitating the formation
on non-lamellar intermediates in the peroxidized membrane.
Finding out the functional group responsible for this aggregation ef-
fect can be of interest. Sphinganine but not sphingosine-1-phosphate
can replace sphingosine (data not shown), probably meaning that the
net positive charge of the sphingoid base headgroup is necessary for
its action. The increased aggregation observed for vesicles containing
negatively-charged lipids also supports a role for the sphingosine posi-
tive charge. Furthermore, long chain alkylamines but not their short
chain analogues can substitute sphingosine, showing that a long alkyl
chain is needed.
Imines or Schiff bases are important chemical compounds arising
from the reaction between an aldehyde and an amine, which are
found in a variety of biological molecules like retinaldehyde [38]. Differ-
ent techniques for their detection have been developed, such as Raman
spectroscopy [39] or 1H-NMR among others [29]. Lipid peroxidation
usually occurs in response to oxidative stress, and a wide diversity of
aldehydes is formed when lipid hydroperoxides break down in biologi-
cal systems [2]. Some of these aldehydes are highly reactive and may
react with the amine group of phospholipids in the membrane, speciﬁ-
cally phosphatidylethanolamine [40–42], leading to the formation of
imines and hence to stable changes in membrane structure. The obser-
vation of imine formation in systems in which sphingosine inducesaggregation of peroxidized vesicles (Fig. 6) conﬁrms the proposed
mechanism of vesicle–vesicle contacts and aggregation.
Our results show that sphingosine does not have the same effect on
oxidized SM:PE:Ch (2:1:1, mol ratio) vesicles or on oxidized vesicles
with other compositions such as PC, PC: PE (2:1) or PC:PE:Ch (2:1:1,
mol ratio). Themain difference between these populations of liposomes
is that in the one containing SM there is a coexistence of liquid-ordered
and liquid-disordered phases, while the PC bilayers are exclusively liq-
uid disordered [15,43]. This can suggest that the presence of membrane
microdomains in the bilayer is an important factor for this aggregation
effect and that some kind of modiﬁcations occurs in LUV composed of
SM:PE:Ch after peroxidation that allows sphingosine to differentially
exert its aggregation effect.
Peroxidation-induced vesicle aggregation is interesting because it
can be used as a model for lipoprotein aggregation under oxidative
conditions [44,45]. Aggregation of lipid droplets and LDL is an early
step necessary for the generation of atherogenic damage. It has been
reported that modiﬁcations of the surface of these particles, which are
enriched in phospholipids (PC, SM), and in cholesterol, can result in
loss of particle stability and affect interaction between them, leading
to their aggregation [46]. A possible molecular mechanism for this, as
we show in this work, could be the formation of imines upon lipid per-
oxidation. Hence, this molecular mechanism of action of sphingosine
when interacting with imine-containing peroxidized bilayers may be
biologically relevant and can help us understand the overall role of
sphingolipids in atherosclerosis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.04.028.
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